Kate Lapane to Skilled Nursing Facilities
This is a "connection" page, showing publications Kate Lapane has written about Skilled Nursing Facilities.
Li L, Jesdale BM, Hume A, Gambassi G, Goldberg RJ, Lapane KL. Who are they? Patients with heart failure in American skilled nursing facilities. J Cardiol. 2018 04; 71(4):428-434.
Alcusky M, Ulbricht CM, Lapane KL. Postacute Care Setting, Facility Characteristics, and Poststroke Outcomes: A Systematic Review. Arch Phys Med Rehabil. 2018 06; 99(6):1124-1140.e9.
Li L, Jesdale BM, Hume A, Gambassi G, Goldberg RJ, Lapane KL. Pharmacotherapy Use in Older Patients With Heart Failure and Reduced Ejection Fraction After a Skilled Nursing Facility Stay. J Card Fail. 2017 Dec; 23(12):843-851.
Lapane KL, Hughes CM. Did the introduction of a prospective payment system for nursing home stays reduce the likelihood of pharmacological management of secondary ischaemic stroke? Drugs Aging. 2006; 23(1):61-9.
Lapane KL, Hughes CM. An evaluation of the impact of the prospective payment system on antidepressant use in nursing home residents. Med Care. 2004 Jan; 42(1):48-58.
Mack DS, Hume AL, Tjia J, Lapane KL. National Trends in Statin Use among the United States Nursing Home Population (2011-2016). Drugs Aging. 2021 05; 38(5):427-439.
Lapane KL, Dubé C, Hume AL, Tjia J, Jesdale BM, Pawasauskas J, Khodyakov D. Priority-Setting to Address the Geriatric Pharmacoparadox for Pain Management: A Nursing Home Stakeholder Delphi Study. Drugs Aging. 2021 04; 38(4):327-340.
Hubsky AR, Noble BN, Hartung DM, Tjia J, Lapane KL, Furuno JP. Opioid prescribing on discharge to skilled nursing facilities. Pharmacoepidemiol Drug Saf. 2020 09; 29(9):1183-1188.
Alcusky M, Hume AL, Fisher M, Tjia J, Goldberg RJ, McManus DD, Lapane KL. Dabigatran Versus Rivaroxaban for Secondary Stroke Prevention in Patients with Atrial Fibrillation Rehabilitated in Skilled Nursing Facilities. Drugs Aging. 2018 12; 35(12):1089-1098.